vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
Nutex Health, Inc. is the larger business by last-quarter revenue ($151.7M vs $134.9M, roughly 1.1× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 7.8%, a 74.7% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 46.2%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
CTRE vs NUTX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $151.7M |
| Net Profit | $111.3M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | — | 20.4% |
| Net Margin | 82.5% | 7.8% |
| Revenue YoY | 55.1% | -41.1% |
| Net Profit YoY | 113.5% | -80.8% |
| EPS (diluted) | $0.52 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $151.7M | ||
| Q3 25 | $132.4M | $267.8M | ||
| Q2 25 | $112.5M | $244.0M | ||
| Q1 25 | $96.6M | $211.8M | ||
| Q4 24 | $86.9M | $257.6M | ||
| Q3 24 | $77.4M | $78.8M | ||
| Q2 24 | $68.9M | $76.1M | ||
| Q1 24 | $63.1M | $67.5M |
| Q4 25 | $111.3M | $11.8M | ||
| Q3 25 | $74.9M | $55.4M | ||
| Q2 25 | $68.5M | $-17.7M | ||
| Q1 25 | $65.8M | $21.2M | ||
| Q4 24 | $52.1M | $61.6M | ||
| Q3 24 | $33.4M | $-8.8M | ||
| Q2 24 | $10.8M | $-364.0K | ||
| Q1 24 | $28.7M | $-364.0K |
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% | ||
| Q1 24 | — | 15.1% |
| Q4 25 | — | 20.4% | ||
| Q3 25 | 58.1% | 48.7% | ||
| Q2 25 | 61.3% | 13.8% | ||
| Q1 25 | — | 38.1% | ||
| Q4 24 | — | 44.4% | ||
| Q3 24 | 43.0% | 12.3% | ||
| Q2 24 | 15.1% | 7.0% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 82.5% | 7.8% | ||
| Q3 25 | 56.6% | 20.7% | ||
| Q2 25 | 60.9% | -7.3% | ||
| Q1 25 | 68.1% | 10.0% | ||
| Q4 24 | 60.0% | 23.9% | ||
| Q3 24 | 43.2% | -11.2% | ||
| Q2 24 | 15.6% | -0.5% | ||
| Q1 24 | 45.6% | -0.5% |
| Q4 25 | $0.52 | $2.34 | ||
| Q3 25 | $0.35 | $7.76 | ||
| Q2 25 | $0.35 | $-2.95 | ||
| Q1 25 | $0.35 | $3.33 | ||
| Q4 24 | $0.30 | $11.56 | ||
| Q3 24 | $0.21 | $-1.72 | ||
| Q2 24 | $0.07 | $-0.07 | ||
| Q1 24 | $0.22 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $185.6M |
| Total DebtLower is stronger | $894.2M | — |
| Stockholders' EquityBook value | $4.0B | $329.4M |
| Total Assets | $5.1B | $918.5M |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $185.6M | ||
| Q3 25 | $712.5M | $166.0M | ||
| Q2 25 | $306.1M | $96.7M | ||
| Q1 25 | $26.5M | $84.7M | ||
| Q4 24 | $213.8M | $40.6M | ||
| Q3 24 | $377.1M | $46.9M | ||
| Q2 24 | $495.1M | $40.8M | ||
| Q1 24 | $451.2M | $30.0M |
| Q4 25 | $894.2M | — | ||
| Q3 25 | $893.8M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $822.1M | — | ||
| Q4 24 | $396.9M | — | ||
| Q3 24 | $396.7M | — | ||
| Q2 24 | $671.1M | — | ||
| Q1 24 | $595.9M | — |
| Q4 25 | $4.0B | $329.4M | ||
| Q3 25 | $4.0B | $317.2M | ||
| Q2 25 | $3.3B | $235.3M | ||
| Q1 25 | $2.9B | $176.9M | ||
| Q4 24 | $2.9B | $132.4M | ||
| Q3 24 | $2.4B | $60.4M | ||
| Q2 24 | $1.9B | $62.7M | ||
| Q1 24 | $1.7B | $63.0M |
| Q4 25 | $5.1B | $918.5M | ||
| Q3 25 | $5.1B | $964.5M | ||
| Q2 25 | $4.7B | $841.0M | ||
| Q1 25 | $3.9B | $761.9M | ||
| Q4 24 | $3.4B | $655.3M | ||
| Q3 24 | $2.9B | $438.5M | ||
| Q2 24 | $2.7B | $422.4M | ||
| Q1 24 | $2.3B | $404.3M |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 3.54× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $70.4M | ||
| Q3 25 | $100.9M | $99.5M | ||
| Q2 25 | $100.8M | $27.3M | ||
| Q1 25 | $71.4M | $51.0M | ||
| Q4 24 | $244.3M | $54.0K | ||
| Q3 24 | $67.2M | $6.8M | ||
| Q2 24 | $53.0M | $13.3M | ||
| Q1 24 | $48.8M | $3.1M |
| Q4 25 | — | $69.0M | ||
| Q3 25 | — | $99.2M | ||
| Q2 25 | — | $26.5M | ||
| Q1 25 | — | $50.9M | ||
| Q4 24 | — | $-341.0K | ||
| Q3 24 | — | $6.2M | ||
| Q2 24 | — | $12.7M | ||
| Q1 24 | — | $2.3M |
| Q4 25 | — | 45.5% | ||
| Q3 25 | — | 37.0% | ||
| Q2 25 | — | 10.9% | ||
| Q1 25 | — | 24.0% | ||
| Q4 24 | — | -0.1% | ||
| Q3 24 | — | 7.8% | ||
| Q2 24 | — | 16.7% | ||
| Q1 24 | — | 3.4% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 0.7% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 3.54× | 5.95× | ||
| Q3 25 | 1.35× | 1.80× | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | 2.40× | ||
| Q4 24 | 4.68× | 0.00× | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTRE
Segment breakdown not available.
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
